Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized double-blind Phase II/III study of JR-013 in hemodialysis patients with renal anemia
jRCT2080220475Phase 3
- Sponsor
- Kissei Pharmaceutical Co., Ltd.
- Start
- Dec 2007
- Modality
- Replacement Enzymes → Therapeutic Enzymes → Recombinant Proteins and Enzymes, Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of JR-013 in anemia of renal disease, sponsored by Kissei Pharmaceutical Co., Ltd.
02
Drugs
JR-013
03
Conditions
anemia of renal disease
Beyond the preview
Go deeper on jRCT2080220475.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220475.